Clinical Schizophrenia and Related Psychoses 
This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.
This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.Turner Mosaicism and Schizoaffective Disorder: The First Reported Case.
Authors: Backes K, Christian T, Agarwal G
PMID: 28548576 [PubMed - in process] (Source: Clinical Schizophrenia and Related Psychoses)
Source: Clinical Schizophrenia and Related Psychoses - May 27, 2017 Category: Psychiatry Tags: Clin Schizophr Relat Psychoses Source Type: research
Folie à Deux in Monozygotic Twins with Cerebral Palsy.
Authors: Francois D, Bander E, D'Agostino M, Swinburne A, Broderick L, Grody MB, Salajegheh A
PMID: 28548577 [PubMed - in process] (Source: Clinical Schizophrenia and Related Psychoses)
Source: Clinical Schizophrenia and Related Psychoses - May 27, 2017 Category: Psychiatry Tags: Clin Schizophr Relat Psychoses Source Type: research
Emotional, Cognitive and Behavioral Reactions to Paranoid Symptoms in Clinical and Nonclinical Populations.
CONCLUSIONS: Clinical and nonclinical expressions of paranoid ideations differ in terms of their cognitive, emotional and behavioral components. It is suggested that, in socially ambiguous situations, paranoid participants (presenting lower thresholds of paranoid schema activation) lose the opportunity to disconfirm their paranoid beliefs by resourcing to more maladaptive coping strategies. Consequently, by dwelling on these thoughts, the amount of time spent thinking about their condition and the disability related to the disease increases.
PMID: 28548578 [PubMed - in process] (Source: Clinical Schizophrenia and Related Psychoses)
Source: Clinical Schizophrenia and Related Psychoses - May 27, 2017 Category: Psychiatry Tags: Clin Schizophr Relat Psychoses Source Type: research
Genetic Variation of the Mu Opioid Receptor (OPRM1) and Dopamine D2 Receptor (DRD2) is Related to Smoking Differences in Patients with Schizophrenia but not Bipolar Disorder.
Authors: Hirasawa-Fujita M, Bly MJ, Ellingrod VL, Dalack GW, Domino EF
Abstract
It is not known why mentally ill persons smoke excessively. Inasmuch as endogenous opioid and dopaminergic systems are involved in smoking reinforcement, it is important to study mu opioid receptor (OPRM1) A118G (rs1799971), dopamine D2 receptor (DRD2) Taq1A (rs1800497) genotypes, and sex differences among patients with schizophrenia or bipolar disorder. Smokers and nonsmokers with schizophrenia (n=177) and bipolar disorder (n=113) were recruited and genotyped. They were classified into three groups: current smoker, former smok...
Source: Clinical Schizophrenia and Related Psychoses - May 27, 2017 Category: Psychiatry Tags: Clin Schizophr Relat Psychoses Source Type: research
A Review of the Impact of Exclusion Criteria on the Generalizability of Schizophrenia Treatment Research.
Authors: Humphreys K
Abstract
Treatment research studies employ criteria that determine which patients are eligible to participate and which are not. When such exclusion criteria produce a treatment research sample that is a small and unrepresentative subset of all patients with a particular disease, clinicians may be hesitant to apply the research results in front-line clinical practice. Accordingly, the present paper reviews the English-language literature on exclusion criteria in schizophrenia treatment research and draws initial conclusions about their impact. Empirically derived estimates of the rate ...
Source: Clinical Schizophrenia and Related Psychoses - May 27, 2017 Category: Psychiatry Tags: Clin Schizophr Relat Psychoses Source Type: research
